PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE - Trademark Details
Status: 701 - Section 8-Accepted
Image for trademark with serial number 85212032
Serial Number
85212032
Registration Number
4089215
Word Mark
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE
Status
701 - Section 8-Accepted
Status Date
2017-03-17
Filing Date
2011-01-06
Registration Number
4089215
Registration Date
2012-01-17
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
David M. Abrahams
Law Office Assigned Location Code
M60
Employee Name
DEFORD, JEFFREY S
Statements
Disclaimer with Predetermined Text
"RESEARCH INSTITUTE"
Goods and Services
Arranging and conducting medical and scientific research projects to assist patients, clinicians, purchasers and policy-makers in making informed health decisions providing and disseminating medical and scientific research information related to how diseases, disorders and other health conditions can be effectively and appropriately prevented, diagnosed, treated and monitored to enable patients, clinicians, purchasers and policy-makers to make informed health decisions
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2011-01-11
Primary Code
042
First Use Anywhere Date
2011-10-00
First Use In Commerce Date
2011-10-00
Current Trademark Owners
Party Name
Patient-Centered Outcomes Research Institute
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (non-profit corporation).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Patient-Centered Outcomes Research Institute
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (non-profit corporation).
Address
Please log in with your Justia account to see this address.
Party Name
Patient-Centered Outcomes Research Institute
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (non-profit corporation).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
David M. Abrahams
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2011-01-10NEW APPLICATION ENTERED IN TRAM
2011-01-11NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2011-03-28ASSIGNED TO EXAMINER
2011-03-29NON-FINAL ACTION WRITTEN
2011-03-29NON-FINAL ACTION E-MAILED
2011-03-29NOTIFICATION OF NON-FINAL ACTION E-MAILED
2011-09-28TEAS RESPONSE TO OFFICE ACTION RECEIVED
2011-09-28CORRESPONDENCE RECEIVED IN LAW OFFICE
2011-09-28TEAS/EMAIL CORRESPONDENCE ENTERED
2011-09-28TEAS CHANGE OF CORRESPONDENCE RECEIVED
2011-10-26FINAL REFUSAL WRITTEN
2011-10-26FINAL REFUSAL E-MAILED
2011-10-26NOTIFICATION OF FINAL REFUSAL EMAILED
2011-11-03TEAS AMENDMENT OF USE RECEIVED
2011-11-04USE AMENDMENT FILED
2011-11-04AMENDMENT TO USE PROCESSING COMPLETE
2011-11-07USE AMENDMENT ACCEPTED
2011-11-08NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
2011-11-04PAPER RECEIVED
2011-11-18ASSIGNED TO LIE
2011-11-18CORRESPONDENCE RECEIVED IN LAW OFFICE
2011-11-18AMENDMENT FROM APPLICANT ENTERED
2011-12-06EXAMINERS AMENDMENT -WRITTEN
2011-12-06EXAMINERS AMENDMENT E-MAILED
2011-12-06NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2011-12-06EXAMINER'S AMENDMENT ENTERED
2011-12-06APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
2011-12-09LAW OFFICE PUBLICATION REVIEW COMPLETED
2012-01-17REGISTERED-SUPPLEMENTAL REGISTER
2017-01-17COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2017-01-26TEAS SECTION 8 RECEIVED
2017-03-17CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2017-03-17REGISTERED - SEC. 8 (6-YR) ACCEPTED
2017-03-17NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
2021-01-17COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED